Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
High-Impact Preventive Healthcare That Works
Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.
Biosimo Chemicals produces sustainable chemicals
Cryowrite is a sample preparation for cryo-electron microscopy.
Aldena Therapeutics is a private biotech startup that invented siRNA-based treatments for dermatological conditions.
Wildbiene + Partner contributes to a balanced ecosystem by providing sustainable pollination and high-quality bee experiences.
Encelta T-cell therapy target and eliminate both blood cancers and solid tumors combined with bispecific antibodies.
KOMP-ACT develops innovative electric motion technology for the industrial automation industry for a carbon-neutral future.
Adoram Therapeutics is a company that uses the benefits of allosteric biochemistry to develop novel therapies.
OncoSwab is creating a point-of-care test to detect lung cancer in high-risk individuals.
Manukai, an ETH Zurich spin-off, creates novel AI models to unlock the value of production data in metal machining.
machineMD combines virtual reality and artificial intelligence into a medical device for the early diagnosis of neurological disorders
MPower Ventures is a technology company that offers funding, software, and solar products to facilitate energy access in emerging markets.
Pace Locator device generates 3D maps of cardiac signal origin using ECG and ECHO data.
Akina provides AI-enabled connected therapy for patients with musculoskeletal conditions.
ASPIVIX is developing a device that makes gynecological procedures more comfortable for patients.
Capt'n Greenfin is a new material for sustainable fishing baits and aims to revolutionize the sportfishing industry in a sustainable way.
Embotech is an IT consulting firm that provides autonomous driving solutions for industrial logistics applications.
Lyfegen is SaaS company that develops rebate management software for the healthcare industry.
Distran is a spin-off from the Autonomous System Lab, ETH Zurich, developing advanced acoustic sensors for industrial applications.
An Innovation Engine In Sports Medicine
identic ai is the leading AI platform turning product images into 3D & AR for e-commerce, interior design, and architecture.
Ymmunobio is a preclinical-stage oncology biotech startup committed to creating advanced cancer patient treatments.
Vatorex enhances honey bee health through an effective and practicable hyperthermic system to fight the varroa mite.
Innosuisse has invested in 213 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Innosuisse's top investment sectors include Biotechnology, Health Care, Manufacturing, Medical, Medical Device. The firm invests across 40 different industry categories.
Among tracked funding rounds, Embotech received $26.3M in a Series B round. Innosuisse's total known invested capital is $612.7M.
Innosuisse's average investment size is $2.9M across its portfolio of 213 companies.
Recent Innosuisse portfolio additions include Nutrix, Gain Therapeutics, Biosimo, Cryowrite, Aldena Therapeutics. These companies were founded in 2020 or later.